These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 23329621)

  • 21. Indicators of adult height outcome in classical 21-hydroxylase deficiency congenital adrenal hyperplasia.
    Muirhead S; Sellers EA; Guyda H;
    J Pediatr; 2002 Aug; 141(2):247-52. PubMed ID: 12183722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone.
    Culig Z; Hobisch A; Cronauer MV; Cato AC; Hittmair A; Radmayr C; Eberle J; Bartsch G; Klocker H
    Mol Endocrinol; 1993 Dec; 7(12):1541-50. PubMed ID: 8145761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of vitamin E deficiency on androgen and corticosterone synthesis.
    Barnes MM; Smith AJ
    Int J Vitam Nutr Res; 1975; 45(3):342-8. PubMed ID: 126972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alternate day prednisone therapy in congenital adrenal hyperplasia: adrenal androgen suppression and normal growth.
    Linder B; Feuillan P; Chrousos GP
    J Clin Endocrinol Metab; 1989 Jul; 69(1):191-5. PubMed ID: 2543690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ACTH stimulation tests and plasma dehydroepiandrosterone sulfate levels in women with hirsutism.
    Siegel SF; Finegold DN; Lanes R; Lee PA
    N Engl J Med; 1990 Sep; 323(13):849-54. PubMed ID: 2168515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Steroid synthesis inhibition by ketoconazole: sites of action.
    Trachtenberg J; Zadra J
    Clin Invest Med; 1988 Feb; 11(1):1-5. PubMed ID: 2966691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Androgen profile in young females with insulin resistance; the importance of 17-Hydroxyprogesterone
    Basaki M; Saeb M; Saeb S
    Gynecol Endocrinol; 2019 Dec; 35(12):1094-1098. PubMed ID: 31674860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hirsutism.
    Mauvais-Jarvis P; Kuttenn F; Mowszowicz I
    Monogr Endocrinol; 1981; 19():1-116. PubMed ID: 6454061
    [No Abstract]   [Full Text] [Related]  

  • 29. [Keyrole of endocrinology in the victory against prostate cancer].
    Labrie F
    Bull Cancer; 2006 Sep; 93(9):949-58. PubMed ID: 16980238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adrenal androgen levels as predictors of outcome in castration-resistant prostate cancer patients treated with combined androgen blockade using flutamide as a second-line anti-androgen.
    Narimoto K; Mizokami A; Izumi K; Mihara S; Sawada K; Sugata T; Shimamura M; Miyazaki K; Nishino A; Namiki M
    Int J Urol; 2010 Apr; 17(4):337-45. PubMed ID: 20202011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways.
    Vis AN; Schröder FH
    BJU Int; 2009 Aug; 104(4):438-48. PubMed ID: 19558559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Importance of the intracrine metabolism of adrenal androgens in androgen-dependent prostate cancer.
    Suzuki K; Nishiyama T; Hara N; Yamana K; Takahashi K; Labrie F
    Prostate Cancer Prostatic Dis; 2007; 10(3):301-6. PubMed ID: 17387321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate cancer stromal cells and LNCaP cells coordinately activate the androgen receptor through synthesis of testosterone and dihydrotestosterone from dehydroepiandrosterone.
    Mizokami A; Koh E; Izumi K; Narimoto K; Takeda M; Honma S; Dai J; Keller ET; Namiki M
    Endocr Relat Cancer; 2009 Dec; 16(4):1139-55. PubMed ID: 19608712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polycystic ovarian disease: the adrenal connection.
    Marouliss GB; Triantafillidis IK
    Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():205-7. PubMed ID: 16641861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absence of nonclassical congenital adrenal hyperplasia in patients with precocious adrenarche.
    Morris AH; Reiter EO; Geffner ME; Lippe BM; Itami RM; Mayes DM
    J Clin Endocrinol Metab; 1989 Oct; 69(4):709-15. PubMed ID: 2550505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in the androgen levels in the ventral prostate of spontaneously hypertensive rats after castration.
    Hu M; Xin D; Chen J; Sun G; Wang Y; Na Y
    BJU Int; 2009 Aug; 104(3):406-11. PubMed ID: 19239443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of prostate cancer in a patient with primary hypogonadism: intratumoural steroidogenesis in prostate cancer tissues.
    Arai S; Shibata Y; Nakamura Y; Kashiwagi B; Uei T; Tomaru Y; Miyashiro Y; Honma S; Hashimoto K; Sekine Y; Ito K; Sasano H; Suzuki K
    Andrology; 2013 Jan; 1(1):169-74. PubMed ID: 23258647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The steroid profile of a virilizing ovarian tumor.
    Soules MR; Abraham GE; Bossen EH
    Obstet Gynecol; 1978 Jul; 52(1):73-8. PubMed ID: 150557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abiraterone inhibits 3β-hydroxysteroid dehydrogenase: a rationale for increasing drug exposure in castration-resistant prostate cancer.
    Li R; Evaul K; Sharma KK; Chang KH; Yoshimoto J; Liu J; Auchus RJ; Sharifi N
    Clin Cancer Res; 2012 Jul; 18(13):3571-9. PubMed ID: 22753664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma androgens in congenital adrenal hyperplasia: androstenedione concentration as an index of adrenal androgen suppression.
    Keenan BS; McNeel R; Barrett GN; Holcombe JH; Kirkland RT; Clayton GW
    J Lab Clin Med; 1979 Nov; 94(5):799-808. PubMed ID: 159330
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.